-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
CONMED (NASDAQ:CNMD) Downgraded by StockNews.com to Sell
CONMED (NASDAQ:CNMD) Downgraded by StockNews.com to Sell
StockNews.com downgraded shares of CONMED (NASDAQ:CNMD – Get Rating) from a hold rating to a sell rating in a research note published on Monday morning.
CONMED Trading Down 3.5 %
Shares of CNMD stock opened at $96.53 on Monday. The stock has a 50-day moving average price of $99.43. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.87 and a quick ratio of 1.43. CONMED has a 12 month low of $87.24 and a 12 month high of $159.11.
Get CONMED alerts:CONMED (NASDAQ:CNMD – Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The firm had revenue of $242.33 million during the quarter, compared to analyst estimates of $235.55 million. CONMED had a positive return on equity of 13.94% and a negative net margin of 10.93%. Equities analysts forecast that CONMED will post 3.32 EPS for the current fiscal year.
About CONMED
(Get Rating)CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
Featured Articles
- Get a free copy of the StockNews.com research report on CONMED (CNMD)
- 3 Hotel Stocks to Consider Checking into After Earnings
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com downgraded shares of CONMED (NASDAQ:CNMD – Get Rating) from a hold rating to a sell rating in a research note published on Monday morning.
斯托克新聞網在週一上午發佈的一份研究報告中將CONMED(納斯達克代碼:CNMD-GET Rating)的股票評級從持有評級下調至賣出評級。
CONMED Trading Down 3.5 %
ConMed股價下跌3.5%
Shares of CNMD stock opened at $96.53 on Monday. The stock has a 50-day moving average price of $99.43. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.87 and a quick ratio of 1.43. CONMED has a 12 month low of $87.24 and a 12 month high of $159.11.
CNMD股票週一開盤報96.53美元。該股的50日移動均價為99.43美元。該公司的債務權益比為1.46,流動比率為2.87,速動比率為1.43。ConMed的12個月低點為87.24美元,12個月高位為159.11美元。
CONMED (NASDAQ:CNMD – Get Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.70 EPS for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The firm had revenue of $242.33 million during the quarter, compared to analyst estimates of $235.55 million. CONMED had a positive return on equity of 13.94% and a negative net margin of 10.93%. Equities analysts forecast that CONMED will post 3.32 EPS for the current fiscal year.
康美德(納斯達克代碼:CNMD-GET Rating)上一次公佈季度收益數據是在5月4日星期三。該公司公佈本季度每股收益為0.70美元,比分析師普遍預期的0.62美元高出0.08美元。該公司本季度營收為2.4233億美元,而分析師預期為2.3555億美元。ConMed的股本回報率為正13.94%,淨利潤率為負10.93%。股票分析師預測,CONMED本財年每股收益將達到3.32歐元。
About CONMED
關於CONMED
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.
康美德公司是一家醫療技術公司,在全球範圍內開發、製造和銷售外科手術器械和相關設備。它提供整形外科產品,包括帶有Y-Knot All-in-One軟組織固定系統的TruShott、Y-Knot All-Sture Anchors和PopLok Nnotless縫合Anchors,這些產品為整形外科醫生修復軟組織損傷提供了獨特的臨牀解決方案,以及使外科醫生能夠進行微創運動醫學手術的配套產品。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on CONMED (CNMD)
- 3 Hotel Stocks to Consider Checking into After Earnings
- How Does Freeport McMoran Inc Compare to Its Sector Competitors?
- Can FuelCell Energy Surge Higher This Year?
- Is It Time to Take a Ride on Cedar Fair Stock?
- Time To Take A Serious Look At Nikola Stock As Production Starts
- 免費獲取StockNews.com關於CONMED的研究報告(CNMD)
- 盈利後考慮登記的3家酒店股票
- 自由港麥克莫蘭公司與其行業競爭對手相比如何?
- 燃料電池能源今年會飆升嗎?
- 是時候在雪松公平股票上兜風了嗎?
- 隨着生產開始,是時候認真看看尼古拉·斯托克了
Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.
接受CONMED日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對CONMED和相關公司的最新新聞和分析師評級的每日簡明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧